Christos Mantzoros Selected Research

HDL Lipoproteins

11/2011

Gestational glucose tolerance and maternal metabolic profile at 3 years postpartum.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Christos Mantzoros Research Topics

Disease

17	Insulin Resistance 12/2022 - 03/2004
16	Obesity 01/2018 - 03/2003
12	Type 2 Diabetes Mellitus (MODY) 12/2022 - 06/2005
7	Prostatic Neoplasms (Prostate Cancer) 06/2015 - 11/2002
6	Breast Neoplasms (Breast Cancer) 07/2017 - 03/2004
5	Non-alcoholic Fatty Liver Disease 12/2022 - 01/2017
5	Neoplasms (Cancer) 01/2018 - 11/2002
4	Weight Gain 07/2017 - 02/2011
3	Alcoholic Fatty Liver 12/2022 - 01/2017
3	Birth Weight (Birth Weights) 11/2019 - 02/2011
3	Inflammation (Inflammations) 08/2017 - 03/2003
3	Metabolic Syndrome (Dysmetabolic Syndrome X) 08/2017 - 01/2006
2	Overweight 01/2020 - 07/2006
2	Gestational Weight Gain 01/2019 - 04/2011
2	Amenorrhea 01/2018 - 10/2014
2	Coronary Disease (Coronary Heart Disease) 08/2017 - 06/2005
2	Atherosclerosis 08/2017 - 01/2007
2	Weight Loss (Weight Reduction) 04/2016 - 06/2005
2	Gestational Diabetes (Gestational Diabetes Mellitus) 11/2011 - 02/2011
2	Endometrial Neoplasms (Endometrial Cancer) 03/2004 - 03/2003
1	Polycystic Ovary Syndrome (Syndrome, Stein-Leventhal) 01/2018
1	Lipodystrophy 01/2018
1	Sleep Deprivation 08/2017
1	Vascular Diseases (Vascular Disease) 08/2017
1	Liver Cirrhosis (Hepatic Cirrhosis) 01/2017
1	Metabolic Diseases (Metabolic Disease) 10/2016
1	Vitamin D Deficiency 04/2016
1	Stroke (Strokes) 01/2016
1	Pediatric Obesity 01/2016
1	Hypogonadism (Hypergonadotropic Hypogonadism) 10/2014
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 10/2014
1	Edema (Dropsy) 07/2014
1	Glucose Intolerance 11/2011
1	Cardiovascular Diseases (Cardiovascular Disease) 07/2011

Drug/Important Bio-Agent (IBA)

18	AdiponectinIBA 01/2020 - 03/2003
17	LeptinIBA 01/2020 - 03/2003
11	Hormones (Hormone)IBA 01/2018 - 03/2003
9	Insulin (Novolin)FDA Link 12/2022 - 11/2002
8	Glucose (Dextrose)FDA LinkGeneric 01/2019 - 07/2007
4	AdipokinesIBA 01/2020 - 01/2007
4	Insulin-Like Growth Factor I (IGF-1)IBA 11/2019 - 11/2002
4	Insulin-Like Growth Factor II (Somatomedin A)IBA 11/2019 - 03/2003
4	Insulin-Like Growth Factor Binding Protein 3IBA 11/2017 - 03/2003
3	C-Reactive ProteinIBA 01/2020 - 11/2011
3	Carrier Proteins (Binding Protein)IBA 11/2019 - 11/2002
3	Adiponectin ReceptorsIBA 09/2011 - 05/2008
3	Proteins (Proteins, Gene)FDA Link 09/2011 - 11/2002
2	Fatty Acids (Saturated Fatty Acids)IBA 12/2022 - 05/2007
2	Vitamin D FDA LinkGeneric 01/2020 - 04/2016
2	Insulin-Like Growth Factor Binding Protein 4IBA 11/2019 - 02/2007
2	Insulin-Like PeptidesIBA 11/2017 - 09/2007
2	LipidsIBA 08/2017 - 10/2016
2	Pioglitazone (Actos)FDA Link 01/2017 - 07/2014
2	INT 131IBA 07/2014 - 03/2012
2	Sex Hormone-Binding GlobulinIBA 02/2009 - 01/2004
2	Prostate-Specific Antigen (Semenogelase)IBA 02/2009 - 08/2003
2	AndrogensIBA 05/2008 - 01/2004
1	Galectin 3 (LGALS3)IBA 12/2022
1	CollagenIBA 12/2022
1	Biosimilar PharmaceuticalsIBA 01/2022
1	Hypoglycemic Agents (Hypoglycemics)IBA 01/2022
1	Liraglutide FDA Link 01/2022
1	Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA 01/2020
1	Cholecalciferol (Vitamin D3)FDA Link 01/2020
1	Peptide Hydrolases (Proteases)FDA Link 11/2019
1	Insulin-Like Growth Factor Binding Protein 5IBA 11/2019
1	Pregnancy-Associated Plasma Protein-A (PAPP-A)IBA 11/2019
1	SodiumIBA 01/2019
1	Sodium-Glucose Transporter 2 InhibitorsIBA 01/2019
1	Neuropeptide YIBA 01/2018
1	Peptides (Polypeptides)IBA 01/2018
1	Rosiglitazone (Avandia)FDA Link 01/2018
1	Gonadotropin-Releasing Hormone (GnRH)FDA Link 01/2018
1	Pro-Opiomelanocortin (Proopiomelanocortin)IBA 01/2018
1	Biomarkers (Surrogate Marker)IBA 08/2017
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2017
1	Ezetimibe (Zetia)FDA Link 01/2017
1	PPAR gammaIBA 01/2017
1	dimethyl sulfone (methylsulfonylmethane)IBA 10/2016
1	hydroxide ionIBA 04/2016
1	ResistinIBA 01/2016
1	2,4-thiazolidinedione (thiazolidinedione)IBA 03/2012
1	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 03/2012
1	HDL LipoproteinsIBA 11/2011
1	Triglycerides (Triacylglycerol)IBA 11/2011
1	Hemoglobins (Hemoglobin)IBA 11/2011
1	Trans Fatty AcidsIBA 07/2011
1	GhrelinIBA 04/2011
1	Testosterone (Sustanon)FDA Link 02/2009
1	SteroidsIBA 02/2009
1	Estradiol (Delestrogen)FDA LinkGeneric 02/2009

Therapy/Procedure

3	Drug Therapy (Chemotherapy) 12/2022 - 01/2020
3	Glycemic Control 01/2017 - 03/2012
2	Prostatectomy (Retropubic Prostatectomy) 02/2009 - 11/2002
1	Therapeutics 12/2022
1	Aftercare (After-Treatment) 07/2017
1	Secondary Prevention 01/2017
1	Transplantation 01/2017
1	Bariatric Surgery 04/2016
1	Hemodilution 07/2014